GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » Total Assets

Autobio Diagnostics Co (SHSE:603658) Total Assets : ¥11,606 Mil (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co Total Assets?

Autobio Diagnostics Co's Total Assets for the quarter that ended in Mar. 2024 was ¥11,606 Mil.

Warning Sign:

If a company builds assets at 29.5% a year, faster than its revenue growth rate of 16.6% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Autobio Diagnostics Co's average Total Assets Growth Rate was 2.50% per year. During the past 3 years, the average Total Assets Growth Rate was 6.50% per year. During the past 5 years, the average Total Assets Growth Rate was 29.50% per year. During the past 10 years, the average Total Assets Growth Rate was 42.00% per year.

During the past 13 years, Autobio Diagnostics Co's highest 3-Year average Total Assets Growth Rate was 69.90%. The lowest was 6.50%. And the median was 47.70%.

Total Assets is connected with ROA %. Autobio Diagnostics Co's annualized ROA % for the quarter that ended in Mar. 2024 was 11.20%. Total Assets is also linked to Revenue through Asset Turnover. Autobio Diagnostics Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.09.


Autobio Diagnostics Co Total Assets Historical Data

The historical data trend for Autobio Diagnostics Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co Total Assets Chart

Autobio Diagnostics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,256.87 8,164.83 9,232.69 10,472.32 11,554.06

Autobio Diagnostics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10,512.37 10,580.20 11,072.22 11,554.06 11,605.92

Autobio Diagnostics Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Autobio Diagnostics Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=8666.331+2887.727
=11,554

Autobio Diagnostics Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=8853.859+2752.064
=11,606

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Autobio Diagnostics Co  (SHSE:603658) Total Assets Explanation

Total Assets is connected with ROA %.

Autobio Diagnostics Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1296.848/( (11554.058+11605.923)/ 2 )
=1296.848/11579.9905
=11.20 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Autobio Diagnostics Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1089.195/( (11554.058+11605.923)/ 2 )
=1089.195/11579.9905
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Autobio Diagnostics Co Total Assets Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Autobio Diagnostics Co (SHSE:603658) Business Description

Traded in Other Exchanges
N/A
Address
No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.
Executives
Miao Yong Jun Director

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines